
Chinese traditional Chinese medicine company founded in August 1995 and based in the Guiyang high-tech industrial development zone in Guizhou, listed on the Shenzhen Stock Exchange in May 2017 under code 002873. A national high-tech enterprise and national key agricultural industrialisation leading enterprise with 231.49 million yuan of registered capital and more than 500 staff, it develops and manufactures finished Chinese medicines for urological and gynaecological disease. Holds close to fifty drug production approvals, of which eleven products are in production including four exclusive varieties such as Kuntai capsules and Ningmitai capsules, with several listed in China's national reimbursement catalogue.
Deja tu valoración